mefloquine has been researched along with Thyroid Cancer, Anaplastic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Champa, D; Cuervo, AM; Di Cristofano, A; Orlacchio, A; Patel, B; Ranieri, M; Shemetov, AA; Verkhusha, VV | 1 |
1 other study(ies) available for mefloquine and Thyroid Cancer, Anaplastic
Article | Year |
---|---|
Obatoclax kills anaplastic thyroid cancer cells by inducing lysosome neutralization and necrosis.
Topics: Animals; Antineoplastic Agents; Apoptosis; Autophagy-Related Protein 5; Autophagy-Related Protein 7; Cell Proliferation; Enzyme Inhibitors; Humans; Indoles; Lysosomes; Mefloquine; Mice; Mice, Knockout; Necrosis; Proto-Oncogene Proteins c-bcl-2; Pyrroles; RNA Interference; RNA, Small Interfering; Spheroids, Cellular; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms; Tumor Cells, Cultured | 2016 |